PreveCeutical™ Medical Inc. Announces Preliminary Results from Phase One of its Venom Re-Engineering Project
August 11, 2017 03:05 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 11, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (FSE:18H) announces encouraging results from the Research and...
PreveCeutical™ Medical Inc. Signs Letter of Intent with UniQuest Pty Limited for Research & Development Program Engineering Peptide Therapeutics for Non-Addictive Analgesics
August 08, 2017 03:05 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 08, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (FSE:18H) announces that on August 7, 2017, the Company signed...
PreveCeutical™ Medical Inc. Begins Trading on the Frankfurt Stock Exchange
August 01, 2017 08:30 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 01, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces the listing of its common shares for trading on the...
PreveCeutical™ Medical Inc. Launches Phase One of Venom Re-Engineering Project
July 25, 2017 08:30 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, July 25, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces the launch of the Company’s multi-faceted Research...
PreveCeutical signs Research and Option Agreement with UniQuest Pty Limited for Developing Dual-Gene Therapy Treatment for Diabetes and Obesity
July 17, 2017 08:30 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, July 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces, further to its news release dated April 13, 2017,...
Update: PreveCeutical Announces the Appointment of Dr. Harendra Parekh as Chief Research Officer
May 17, 2017 16:30 ET
|
PreveCeutical Medical Inc
**NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES** VANCOUVER, British Columbia, May 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc....
PreveCeutical Announces the Appointment of Dr. Harendra Parekh as Chief Research Officer
May 17, 2017 09:00 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, May 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilizing nature and science for the benefit of...
PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Extraction, Formulation and Ex Vivo Evaluation of Cannabinoids (“CBD”s) for Delivery via Sol-Gels
April 24, 2017 08:30 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, April 24, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilising nature and science for the benefit of...
PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Development of Caribbean Blue Scorpion Venom-Derived Natural & Synthetic Peptides
April 20, 2017 09:00 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, April 20, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilizing nature and science for the benefit of...
PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest Pty Limited
April 13, 2017 09:00 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, April 13, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilizing nature and science for the benefit of...